|

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

RECRUITINGN/ASponsored by National University of Malaysia
Actively Recruiting
PhaseN/A
SponsorNational University of Malaysia
Started2024-03-24
Est. completion2026-06-01
Eligibility
Age20 Years – 45 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06319560

Summary

The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment

Eligibility

Age: 20 Years – 45 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Singleton
* Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus

Exclusion Criteria:

* autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
* chronic kidney disease
* fetal anomaly
* women on steroid therapy
* diabetic retinopathy
* known thalassaemia or thalassaemia carrier

Conditions3

DiabetesDiabetes in PregnancyType 2 Diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.